الصفحة الرئيسية>>H-Tyr-L-1,2,3,4-tetrahydroisoquinoline-3-carboxamide . HCl

H-Tyr-L-1,2,3,4-tetrahydroisoquinoline-3-carboxamide . HCl

رقم الكتالوجGA22978

Tyr-Tic-amide and its epimer are the first example for opioid peptides consisting of a message domain of only two residues. In addition, they are the first opioid dipeptides with significant opioid activity and represent a first meaningful link among peptide opioids and alkaloid opiates and thus may form the basis for an unified receptor site model. It has been shown furthermore that peptides containing the Tyr-Tic motif , as TIPP H-5776, act as very selective antagonists for δ-opioid receptors and those containing Tyr-D-Tic as non-selective μ-agonists.

Products are for research use only. Not for human use. We do not sell to patients.

H-Tyr-L-1,2,3,4-tetrahydroisoquinoline-3-carboxamide . HCl التركيب الكيميائي

Cas No.: 154121-70-7

الحجم السعر المخزون الكميّة
50mg
486٫00
متوفر
250mg
1946٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Tyr-Tic-amide and its epimer are the first example for opioid peptides consisting of a message domain of only two residues. In addition, they are the first opioid dipeptides with significant opioid activity and represent a first meaningful link among p

مراجعات

Review for H-Tyr-L-1,2,3,4-tetrahydroisoquinoline-3-carboxamide . HCl

Average Rating: 5 ★★★★★ (Based on Reviews and 13 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for H-Tyr-L-1,2,3,4-tetrahydroisoquinoline-3-carboxamide . HCl

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.